A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...
New research highlights nasal spray drug’s potential to counter Alzheimer’s by targeting brain enzyme dysfunction.
Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...
The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...
Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter publish ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at Texas A&M University College of Medicine. Alzheimer's is the most common ...
A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that by inhibiting the ...
It can be a symptom of nasal furunculosis, a deep infection of the hair follicle within the nasal vestibule, the area just inside the nostril. Fortunately, it’s fairly easy to treat — but if ...
Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to ...
In a new study from Texas A & M University College of Medicine, researchers have used a nasal spray to target microglia and astrocytes — cells that cause neuroinflammation (brain inflammation) — ...